Week In Review: 3SBio Rises 5% After $711 Million IPO

3SBio, a Shenyang biotech, rose 5% in its first day of trading in Hong Kong following the company's $711 million IPO (see story). Even though the IPO was priced at 43 times earnings,
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.